Hardcastle & Waud Mfg Co Ltd Valuation Shifts to Very Attractive Amid Specialty Chemicals Sector Dynamics

39 minutes ago
share
Share Via
Hardcastle & Waud Mfg Co Ltd has witnessed a significant shift in its valuation parameters, moving from a fair to a very attractive rating. This change reflects improved price-to-earnings and price-to-book value ratios relative to its historical averages and peer group, signalling a potential opportunity for investors within the specialty chemicals sector.
Hardcastle & Waud Mfg Co Ltd Valuation Shifts to Very Attractive Amid Specialty Chemicals Sector Dynamics

Valuation Metrics Signal Renewed Appeal

As of 18 Sep 2026, Hardcastle & Waud’s price-to-earnings (P/E) ratio stands at 10.52, a level that is notably lower than many of its industry peers and well below its own historical highs. This P/E multiple suggests the stock is trading at a discount relative to its earnings, enhancing its price attractiveness. Complementing this, the price-to-book value (P/BV) ratio is at 1.09, indicating the market values the company close to its net asset value, which is often considered a threshold for value investors seeking stable companies with tangible assets.

Further valuation indicators reinforce this positive outlook. The enterprise value to EBITDA (EV/EBITDA) ratio is 8.97, which is modest compared to the sector’s more expensive players such as Retina Paints, which trades at an EV/EBITDA of 27.15. This disparity highlights Hardcastle & Waud’s relative undervaluation in the specialty chemicals space.

Comparative Peer Analysis

When benchmarked against peers, Hardcastle & Waud’s valuation stands out. Shalimar Paints and Kamdhenu Venture are currently classified as risky investments due to loss-making operations, with Shalimar Paints showing a negative EV/EBIT of -29.38. Meanwhile, MCON Rasayan, another specialty chemicals company, holds an attractive valuation with a P/E of 9.66 and EV/EBITDA of 6.16, slightly more favourable but comparable to Hardcastle & Waud’s metrics.

This peer comparison underscores Hardcastle & Waud’s improved standing, especially given its micro-cap status, which often entails higher volatility and risk. The company’s valuation grade upgrade from fair to very attractive on 25 May 2026 reflects this positive repositioning in the market.

Operational Efficiency and Returns

Beyond valuation, Hardcastle & Waud’s operational metrics provide further context. The company’s return on capital employed (ROCE) is 9.92%, while return on equity (ROE) is 10.31%. These figures indicate moderate profitability and efficient capital utilisation, which support the sustainability of earnings underpinning the current valuation.

Investors should note that the PEG ratio is reported as 0.00, which may indicate either a lack of meaningful earnings growth projections or data unavailability. This absence of growth premium suggests the current valuation is primarily driven by stable earnings rather than anticipated rapid expansion.

Price Movement and Market Performance

Hardcastle & Waud’s stock price closed at ₹810.00 on 18 Sep 2026, down 2.87% from the previous close of ₹833.95. The day’s trading range was between ₹790.00 and ₹833.95, with a 52-week high of ₹1,048.00 and a low of ₹602.25. Despite the recent short-term dip, the stock has demonstrated strong long-term performance, with a five-year return of 199.06% compared to the Sensex’s 25.92% over the same period.

Year-to-date, the stock has gained 10.51%, outperforming the Sensex which is down 12.80%. Even over a decade, Hardcastle & Waud’s return of 170.45% slightly surpasses the Sensex’s 159.85%, highlighting its resilience and growth potential within the specialty chemicals sector.

Perfect timing to enter! This Small Cap from IT - Software just turned profitable with growth momentum clearly building up. Get in before the broader market notices!

  • - New profitability achieved
  • - Growth momentum building
  • - Under-the-radar entry

Get In Before Others →

Mojo Score and Rating Upgrade

Hardcastle & Waud currently holds a Mojo Score of 58.0, which places it in the ‘Hold’ category, upgraded from a previous ‘Sell’ rating on 25 May 2026. This upgrade reflects improved fundamentals and valuation attractiveness, signalling a more balanced risk-reward profile for investors. The micro-cap market capitalisation grade remains unchanged, indicating the company’s relatively small size within the broader specialty chemicals sector.

Sector Context and Risk Considerations

The specialty chemicals sector is characterised by cyclical demand and sensitivity to raw material price fluctuations. Hardcastle & Waud’s valuation improvement comes at a time when some peers face profitability challenges, as evidenced by loss-making companies like Shalimar Paints and Kamdhenu Venture. This contrast enhances Hardcastle & Waud’s relative appeal but also underscores the importance of monitoring sector-wide risks.

Investors should also consider the company’s dividend yield, which is currently not available, suggesting either no dividend payout or insufficient data. This factor may influence income-focused investors’ decisions.

Outlook and Investment Implications

The shift to a very attractive valuation grade, combined with solid returns and operational metrics, positions Hardcastle & Waud as a noteworthy candidate for investors seeking exposure to the specialty chemicals sector at a reasonable price. While the stock’s recent short-term price decline may cause some caution, its long-term outperformance relative to the Sensex and peers supports a constructive outlook.

Holding Hardcastle & Waud Mfg Co Ltd from Specialty Chemicals? See if there's a smarter choice! SwitchER compares it with peers and suggests superior options across market caps and sectors!

  • - Peer comparison ready
  • - Superior options identified
  • - Cross market-cap analysis

Switch to Better Options →

Conclusion

Hardcastle & Waud Mfg Co Ltd’s recent valuation upgrade to very attractive status marks a pivotal moment for the company within the specialty chemicals sector. Its favourable P/E and P/BV ratios, combined with solid returns and operational efficiency, suggest the stock is currently undervalued relative to its peers and historical benchmarks. While short-term price volatility persists, the company’s long-term performance and improved rating provide a compelling case for investors to reassess its role in their portfolios.

As always, investors should weigh sector risks and company-specific fundamentals carefully, but the current valuation landscape presents an opportunity worth considering for those seeking value in the specialty chemicals space.

{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News